GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 48 filers reported holding GALERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,087 | -94.4% | 69,029 | 0.0% | 0.00% | – |
| Q2 2023 | $215,370 | +187.5% | 69,029 | +135.9% | 0.00% | – |
| Q1 2023 | $74,921 | +71.8% | 29,266 | 0.0% | 0.00% | – |
| Q4 2022 | $43,606 | -14.5% | 29,266 | 0.0% | 0.00% | – |
| Q3 2022 | $51,000 | +112.5% | 29,266 | +61.0% | 0.00% | – |
| Q2 2022 | $24,000 | -44.2% | 18,175 | 0.0% | 0.00% | – |
| Q1 2022 | $43,000 | -48.2% | 18,175 | 0.0% | 0.00% | – |
| Q4 2021 | $83,000 | -43.5% | 18,175 | 0.0% | 0.00% | – |
| Q3 2021 | $147,000 | +1.4% | 18,175 | +22.8% | 0.00% | – |
| Q2 2021 | $145,000 | -82.7% | 14,795 | -84.4% | 0.00% | – |
| Q1 2021 | $838,000 | -17.0% | 94,945 | -3.9% | 0.00% | – |
| Q4 2020 | $1,010,000 | +7.4% | 98,763 | -5.0% | 0.00% | – |
| Q3 2020 | $940,000 | +26.3% | 103,945 | -0.2% | 0.00% | – |
| Q2 2020 | $744,000 | +134.7% | 104,185 | +211.8% | 0.00% | – |
| Q1 2020 | $317,000 | -27.0% | 33,411 | +1.3% | 0.00% | – |
| Q4 2019 | $434,000 | – | 32,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $107,375 | 0.09% |
| Sofinnova Investments, Inc. | 3,083,712 | $539,958 | 0.03% |
| MANCHESTER FINANCIAL INC | 49,900 | $8,738 | 0.00% |
| Good Life Advisors, LLC | 31,250 | $5,472 | 0.00% |
| Blackstone Inc. | 1,678,984 | $293,822 | 0.00% |
| Pinnacle Wealth Management Advisory Group, LLC | 47,695 | $8,351 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 302,506 | $52,939 | 0.00% |
| GOLDMAN SACHS GROUP INC | 11,974 | $2,097 | 0.00% |
| MORGAN STANLEY | 2,834 | $497 | 0.00% |
| Invesco Ltd. | 157,653 | $27,605 | 0.00% |